Cargando…
Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity
BACKGROUND: Fibromyalgia syndrome (FMS) is characterized by altered pain perception with chronic, widespread musculoskeletal pain. The relationship between nitric oxide, oxidative stress and the severity of FMS has not been studied. This study evaluated NO levels in plasma, LPO products and antioxid...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Medical Biochemists of Serbia, Belgrade
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526024/ https://www.ncbi.nlm.nih.gov/pubmed/33033448 http://dx.doi.org/10.2478/jomb-2019-0033 |
_version_ | 1783588794833829888 |
---|---|
author | Shukla, Varsha Kumar, Das Siddharth Ali, Mahdi Abbas Agarwal, Shweta Khandpur, Sukhanshi |
author_facet | Shukla, Varsha Kumar, Das Siddharth Ali, Mahdi Abbas Agarwal, Shweta Khandpur, Sukhanshi |
author_sort | Shukla, Varsha |
collection | PubMed |
description | BACKGROUND: Fibromyalgia syndrome (FMS) is characterized by altered pain perception with chronic, widespread musculoskeletal pain. The relationship between nitric oxide, oxidative stress and the severity of FMS has not been studied. This study evaluated NO levels in plasma, LPO products and antioxidants in Red Cell lysate in patients of FMS and correlated it with disease severity. METHODS: 105 FMS patients who fulfilled 1990 ACR Criteria and 105 age- and sex-matched healthy controls were recruited over two years from 2013 to 2015. Antioxidative enzyme activity was assessed by the estimation of catalase, glutathione peroxidase (GPx) and glutathione reductase (GR) and superoxide dismutase (SOD). Nitric oxide in plasma, MDA marker of lipid per - oxidation (LPO) in the lysate was donen for estimating oxidative stress. FIQR was used to assess the severity of fibromyalgia. RESULTS: The catalase, superoxide dismutase, glutathione reductase and glutathione peroxidase levels were significantly low in patients than controls (p<0.001). Plasma NO levels and LPO were also significantly high (p<0.05). NO and LPO levels showed a significant positive correlation with FIQR (r: 0.57, 0.8 and p: <0.001) whereas a negative correlation was observed between antioxidants (Cat, GR and GPx, but not SOD) and FIQR. CONCLUSIONS: Low antioxidants and raised LPO in RBC lysate in patients with FM together with high plasma NO correlated with the severity of FMS. |
format | Online Article Text |
id | pubmed-7526024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Society of Medical Biochemists of Serbia, Belgrade |
record_format | MEDLINE/PubMed |
spelling | pubmed-75260242020-10-07 Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity Shukla, Varsha Kumar, Das Siddharth Ali, Mahdi Abbas Agarwal, Shweta Khandpur, Sukhanshi J Med Biochem Original Paper BACKGROUND: Fibromyalgia syndrome (FMS) is characterized by altered pain perception with chronic, widespread musculoskeletal pain. The relationship between nitric oxide, oxidative stress and the severity of FMS has not been studied. This study evaluated NO levels in plasma, LPO products and antioxidants in Red Cell lysate in patients of FMS and correlated it with disease severity. METHODS: 105 FMS patients who fulfilled 1990 ACR Criteria and 105 age- and sex-matched healthy controls were recruited over two years from 2013 to 2015. Antioxidative enzyme activity was assessed by the estimation of catalase, glutathione peroxidase (GPx) and glutathione reductase (GR) and superoxide dismutase (SOD). Nitric oxide in plasma, MDA marker of lipid per - oxidation (LPO) in the lysate was donen for estimating oxidative stress. FIQR was used to assess the severity of fibromyalgia. RESULTS: The catalase, superoxide dismutase, glutathione reductase and glutathione peroxidase levels were significantly low in patients than controls (p<0.001). Plasma NO levels and LPO were also significantly high (p<0.05). NO and LPO levels showed a significant positive correlation with FIQR (r: 0.57, 0.8 and p: <0.001) whereas a negative correlation was observed between antioxidants (Cat, GR and GPx, but not SOD) and FIQR. CONCLUSIONS: Low antioxidants and raised LPO in RBC lysate in patients with FM together with high plasma NO correlated with the severity of FMS. Society of Medical Biochemists of Serbia, Belgrade 2020-01-23 2020-01-23 /pmc/articles/PMC7526024/ /pubmed/33033448 http://dx.doi.org/10.2478/jomb-2019-0033 Text en 2020 Varsha Shukla, Das Siddharth Kumar, Mahdi Abbas Ali, Shweta Agarwal, Sukhanshi Khandpur, published by CEON/CEES https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License. |
spellingShingle | Original Paper Shukla, Varsha Kumar, Das Siddharth Ali, Mahdi Abbas Agarwal, Shweta Khandpur, Sukhanshi Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
title | Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
title_full | Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
title_fullStr | Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
title_full_unstemmed | Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
title_short | Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
title_sort | nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526024/ https://www.ncbi.nlm.nih.gov/pubmed/33033448 http://dx.doi.org/10.2478/jomb-2019-0033 |
work_keys_str_mv | AT shuklavarsha nitricoxidelipidperoxidationproductsandantioxidantsinprimaryfibromyalgiaandcorrelationwithdiseaseseverity AT kumardassiddharth nitricoxidelipidperoxidationproductsandantioxidantsinprimaryfibromyalgiaandcorrelationwithdiseaseseverity AT alimahdiabbas nitricoxidelipidperoxidationproductsandantioxidantsinprimaryfibromyalgiaandcorrelationwithdiseaseseverity AT agarwalshweta nitricoxidelipidperoxidationproductsandantioxidantsinprimaryfibromyalgiaandcorrelationwithdiseaseseverity AT khandpursukhanshi nitricoxidelipidperoxidationproductsandantioxidantsinprimaryfibromyalgiaandcorrelationwithdiseaseseverity |